Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices ...

Data demonstrated multiple clinical benefits beyond linear growth — NDA supported by data from three randomized, double-blind ...

Backed by advanced in vitro and in vivo research, Pureblome™ promotes overall skin regeneration through a dual action ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that the National Medical Products Administration (NMPA) of ...

Cardiac macrophages in newborn mice promoted heart cell proliferation after injury, offering a potential approach to ...

This study uses multimodal imaging—including SHG, SIMS, and TEM—to reveal how fibroblasts interact with 3D collagen scaffolds ...

Christina Coughlin, M.D., Ph.D., Chief Executive Officer of Avacta, said: "We made a strong start to 2025, continuing to make ...

AVA6000 Phase 1b expansion cohorts enrolling with data targeted for later in 2025 AVA6103 IND-enabling studies underway with a Phase 1 trial anticipated to begin in the first quarter of 2026 Multiple ...

The Indo-Japan team has standardized the tissue engineering procedure, engraftment of cells on epithelial surface, transport of buccal tissue from hospital to lab and harvested cells back to hospital ...